Press release
Peptide Based Metabolic Disorders Therapeutics Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Peptide Based Metabolic Disorders Therapeutics Market Share
The growing prevalence of obesity is expected to drive the expansion of the peptide-based metabolic disorders therapeutic market. Obesity, characterized by excess body fat, is a significant health risk and its increasing incidence is linked to factors such as sedentary lifestyles, poor diets, genetic factors, and environmental influences. Peptide-based therapies aim to manage obesity by regulating metabolic functions, improving insulin sensitivity, and controlling appetite, leading to better health outcomes and a reduction in long-term health risks. For example, The British Diabetic Association reports that in April 2024, 4.4 million people in the UK have diabetes, with another 1.2 million potentially undiagnosed. The 2022-2023 figures show an increase of 167,822 cases compared to the previous year, highlighting the growing demand for peptide-based therapeutics.
Get Your Peptide Based Metabolic Disorders Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report
What growth opportunities are expected to drive the peptide based metabolic disorders therapeutics market's CAGR through 2034?
The peptide-based metabolic disorders therapeutics market has shown rapid growth in recent years, with its value expected to rise from $29.89 billion in 2024 to $34.4 billion in 2025, reflecting a CAGR of 15.1%. The growth is driven by the increasing prevalence of metabolic disorders, advancements in peptide synthesis technologies, rising healthcare spending, an aging population, expanding biopharmaceutical sector, regulatory approvals for new therapies, and greater awareness of personalized medicine.
The peptide-based metabolic disorders therapeutics market is expected to see rapid growth, reaching $59.85 billion by 2029 with a CAGR of 14.8%. Growth is driven by novel peptide analogs, rising R&D investments, precision medicine, market expansion, and drug development collaborations. Key trends include AI in drug discovery, personalized therapies, CRISPR/Cas9 genetic therapies, wearable devices for patient monitoring, oral peptide formulations, digital therapeutics, and biobanking.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16764&type=smp
What are the emerging trends shaping the future of the peptide based metabolic disorders therapeutics market?
Major companies in the peptide-based metabolic disorders therapeutics market are developing peptide-based treatments, such as anti-diabetic biosimilars, to expand treatment options for patients. These biosimilars mimic established anti-diabetic drugs and offer comparable efficacy at potentially lower costs. For example, in January 2024, Glenmark Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Lirafit, a biosimilar of the anti-diabetic drug Liraglutide, in India. This drug aims to improve glycemic control, promote weight loss, and enhance cardiovascular safety for patients managing diabetes.
Which growth-oriented segments of the peptide based metabolic disorders therapeutics market are leading the industry's development?
The peptide based metabolic disorders therapeutics market covered in this report is segmented -
1) By Drug Type: Liraglutide, Exenatide, Other Drug Type
2) By Application: Lysosomal Storage Diseases, Diabetes, Obesity, Hypercholesterolemia, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Liraglutide: Brand: Saxenda, Brand: Victoza, Generic Liraglutide, Liraglutide For Type 2 Diabetes, Liraglutide For Obesity
2) By Exenatide: Brand: Byetta, Brand: Bydureon, Exenatide For Type 2 Diabetes, Extended-Release Exenatide, Generic Exenatide
3) By Other Drug Type: Semaglutide, Dulaglutide, Albiglutide, Lixisenatide, GLP-1 Receptor Agonists, Pramlintide, Other Peptide-Based Drugs For Metabolic Disorders
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16764
What regions are leading the charge in the peptide based metabolic disorders therapeutics market?
North America was the largest region in the peptide based metabolic disorders therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide based metabolic disorders therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the peptide based metabolic disorders therapeutics market?
Major companies operating in the peptide based metabolic disorders therapeutics market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Eli Lilly Company, Amgen Inc., Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Jazz Pharmaceuticals plc, Ipsen S.A, BioMarin Pharmaceutical Inc., Amarin Corporation plc, PolyPeptide Group
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16764&type=smp
What Is Covered In The Peptide Based Metabolic Disorders Therapeutics Global Market Report?
•Market Size Forecast: Examine the peptide based metabolic disorders therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the peptide based metabolic disorders therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the peptide based metabolic disorders therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the peptide based metabolic disorders therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the peptide based metabolic disorders therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the peptide based metabolic disorders therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the peptide based metabolic disorders therapeutics market.
•Competitive Landscape: Review strategic developments in the peptide based metabolic disorders therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Metabolic Disorders Therapeutics Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3931821 • Views: …
More Releases from The Business Research Company
Booming Construction Activity Drives Growth of the Voice Gender Conversion Artif …
What Will the Voice Gender Conversion Artificial Intelligence (AI) Market Size Reach by 2025?
The sphere of artificial intelligence dedicated to voice gender conversion has witnessed remarkable, rapid expansion lately, projected to ascend from a valuation of $1.06 billion in 2024 to $1.33 billion the following year, exhibiting a compound annual growth rate of 25.5%. This historical upward trajectory is fueled significantly by the wider integration of AI within the media…
Future of the Vertical Video Templates Marketplaces Market: Key Innovations and …
What Market Value Will the Vertical Video Templates Marketplaces Industry Achieve by 2025?
The market for vertical video templates has experienced substantial expansion lately, projected to move from a valuation of $1.24 billion in the year 2024 to reach $1.45 billion by 2025, reflecting a compound annual growth rate (CAGR) of 16.7%. This historical upward trajectory is primarily fueled by several key factors: a widespread embrace of brief video formats, the…
Global Vector Index Freshness Management Market Expected to Grow at 22.5% CAGR, …
What Will the Vector Index Freshness Management Market Size Reach by 2025?
The market valuation for vector index freshness management has experienced rapid expansion lately, escalating from a figure of $1.35 billion in 2024 to an anticipated $1.65 billion just one year later in 2025, reflecting a compound annual growth rate (CAGR) of 22.8%; this substantial historical uplift is primarily fueled by the amplified deployment of large language models, heightened attention…
2025-2034 User-Generated Content Rights Platform Market Evolution: Emerging Oppo …
"What Is the Projected Size of the User-Generated Content Rights Platform Market by 2025?
The market encompassing platforms for user-generated content rights has seen rapid expansion lately, projected to increase its valuation from 1.74 billion US dollars in 2024 to 2.15 billion US dollars the subsequent year, reflecting a compound annual growth rate (CAGR) of 23.3%. This historical expansion primarily stems from several contributing factors, notably the surge in digitally produced…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
